Dellinger EP. Infecções cirúrgicas e escolha dos antimicrobianos. Sabiston: tratado de cirurgia. 2003:182-200.

Fry DE. Surgical infections. 1995.

Howard RJ, Simmons RL. Surgical infectious diseases. 1994.

de Lalla F. Surgical prophylaxis in practice. J Hosp Infect. 2002;50(^sA):S9-12.

Akalin HE. Surgical prophylaxis: the evolution of guidelines in an era of cost containment. J Hosp Infect. 2002;50(^sA):S3-7.

Burke JF. Identification of the source of staphylococci contaminating the surgical wound during operation. Ann Surg. 1963;158:898-904.

Dellinger EP, Ehrenkranz NJ. Surgical infections. Hospital infections. 1998:571-85.

Cruse PJ, Foord R. The epidemiology of wound infection: A prospective study of 62,939 wounds. Surg Clin North Am. 1980;60:27-40.

Linton RR. The prophylactic use of the antibiotics in clean surgery. Surg Gynecol Obstet. 1961;112:218-20.

Greif R, Akça O, Horn EP, Kurz A, Sessler DI. Supplemental perioperative oxygen to reduce the incidence of surgical-wound infection: Outcomes Research Group. N Engl J Med. 2000;342:161-7.

Kurz A, Sessler DI, Lenhardt R. Perioperative normothermia to reduce the incidence of surgical-wound infection and shorten hospitalization: Study of Wound Infection and Temperature Group. N Engl J Med. 1996;334:1209-15.

Page CP, Bohnen JM, Fletcher JR, McManus AT, Solomkin JS, Wittmann DH. Antimicrobial prophylaxis for surgical wounds: Guidelines for clinical care. Arch Surg. 1993;128:79-88.

Manian FA, Meyer L. Comprehensive surveillance of surgical wound infections in outpatient and inpatient surgery. Infect Control Hosp Epidemiol. 1990;11:515-20.

Olson MM, Lee JT Jr. Continuous, 10-year wound infection surveillance: Results, advantages, and unanswered questions. Arch Surg. 1990;125:794-803.

Bailey IS, Karran SE, Toyn K, Brough P, Ranaboldo C, Karran SJ. Community surveillance of complications after hernia repair surgery. BMJ. 1992;304:469-71.

Platt R, Zaleznik DF, Hopkins CC. Perioperative antibiotic prophylaxis for herniorrhaphy and breast surgery. N Engl J Med. 1990;322:153-60.

Platt R, Zucker JR, Zaleznik DF. Prophylaxis against wound infection following herniorrhaphy or breast surgery. J Infect Dis. 1992;166:556-60.

Lewis RT, Weigand FM, Mamazza J, Lloyd-Smith W, Tataryn D. Should antibiotic prophylaxis be used routinely in clean surgical procedures: a tentative yes. Surgery. 1995;118:742-6.

Leaper D. Use of antibiotic prophylaxis in clean non-implant wounds. J Antimicrob Chemother. 1998;41:501-4.

de Lalla F. Antimicrobial chemotherapy in the control of surgical infectious complications. J Chemother. 1999;11:440-5.

Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection. Am J Infect Control. 1999;27:97-132.

Kernodle DS, Classen DC, Burke JP, Kaiser AB. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. JAMA. 1990;263:961-9.

Kreter B, Woods M. Antibiotic prophylaxis for cardiothoracic operations: Meta-analysis of thirty years of clinical trials. J Thorac Cardiovasc Surg. 1992;104:590-9.

Pehlivan M, Hayran M, Akalin HE. Antibacterial use at Iiacettepe University Hospital: Differences between specialities on appropriate use. .

Fraise AP. Guidelines for the control of methicillin-resistant Staphylococcus aureus. J Antimicrob Chemother. 1998;42:287-9.

Katzung BG, Ehrlich KS. Drogas utilizadas em infecções bacterianas, fúngicas e virais. Farmacologia clínica. 1991:132-80.

Tice AD. Pharmacoeconomic considerations in the ambulatory use of parenteral cephalosporins. Drugs. 2000;59:29-35.

Barrionuevo CE, Koning MB, Capasso R, Barrionuevo R. Eficácia do uso da cefazolina per-operatória em dose única na profilaxia da infecçäo pós-operatória em cirurgias näo infectadas. Rev Bras Med Otorrinolaringol. 1995;2:432.

Moya M, Antonio D, Collazo Herrera M, Pisonero Socías J, Pardo Gómez G. Evaluación económica del uso de Cefazolina versus Ceftriazona en la profilaxis perioperatoria. Rev cuba Farm. 2001;35:187-191.

Valle Panchana G, Abarca Aguilar F, Rivera Escalante V, Rivera Drouet R. Cefazolina y su uso como profilaction en cirurgia. Rev Univ Guayaquil. 1987;2:59-68.

Baca Tinoco C. Uso de antibiótico para profilaxis quirúrgica en el servicio de cirugía general del HEODRA, en el período enero a diciembre 2003. León. 2004:45.

Saab A, Suckerman-Voldman E, Rodríguez AR. Profilaxia con antibióticos en cirugía: experiencia en el Servicio de Emergencia de un Hospital Universitário. Antibiot Infecc. 1995;5:13-6.

Bencini PL, Signorini M, Galimberti M, Cavicchini S, Caputo R. Preoperative antibiotic prophylaxis in flexural surgery of difficult contamination-prone areas of the skin: the utility of a single dose of antibiotic. J Dermatol Treat. 1994;5:17-9.

Fonseca SN, Kunzle SR, Junqueira MJ, Nascimento RT, de Andrade JI, Levin AS. Implementing 1-dose antibiotic prophylaxis for prevention of surgical site infection. Arch Surg. 2006;141:1109-14.

Iribarren O, Araujo M. Effect of antimicrobial prophylaxis on the incidence of infections in clean surgical wounds in hospitals undergoing renovation: Infection control and hospital epidemiology. Infect Control Hosp Epidemiol. 2006;27:1372-6.

Fatica CA, Gordon SM, Zins JE. The role of preoperative antibiotic prophylaxis in cosmetic surgery. Plast Reconstr Surg. 2002;109:2570-3.

Moreira RC, Timi JR, Abrão E. Estudo prospectivo da antibioticoprofilaxia em operaçöes de fístula artério-venosa para diálise. Rev Angiol Cir Vasc. 1992;1:108-11.

Del Canto Harboe E, Urbina CR. Estudio de portación nasal de staphylococcus aureus en estudiantes de medicina de la Universidad de Santiago de Chile. Clin Cienc. 2001;1:10-14.

Robledo JÁ, López J, Sierra P, Robledo C, Pfaller MA, Jones RN. El programa de vigilancia antimicrobiana SENTRY en Colombia: hallazgos iniciales en tres hospitales de Medellín. Infectio. 1999;3:100-7.

Terzi C, Kilic D, Unek T, Hosgorler F, Fuzun M, Ergor G. Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinicalstudy. J Hosp Infect. 2005;60:340-7.

Thomas R, Alvino P, Cortino G R. Long-acting versus short-acting cephalosporins for preoperative prophylaxis in breast surgery: a randomized double-blind trial involving 1,766. Chemotherapy. 1999;45:217-23.

Marroni M, Cao P, Fiorio M. Prospective, randomized, double-blind trial comparing teicoplanin and cefazolin as antibiotic prophylaxis in prosthetic vascular surgery. Eur J Clin Microbiol Infect Dis. 1999;18:175-8.

Allababidi S, Shah JC. Efficacy and pharmacokinetics of site-specific cefazolin delivery using biodegradable implants in the prevention of post-operative wound infections. Pharm Res. 1998;15:325-33.

Giacometti A, Cirioni O, Ghiselli R. Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular-graft infection. Antimicrob Agents Chemother. 2000;44:2842-4.

Yasim A, Gul M, Atahan E, Ciragil P, Aral M, Ergun Y. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat. Eur J Vasc Endovasc Surg. 2006;31:274-9.

Earnshaw JJ. Methicillin-resistant Staphylococcus aureus: vascular surgeons should fight back. Eur J Vasc Endovasc Surg. 2002;24:283-6.

Murphy GJ, Pararajasingam R, Nasim A, Dennis MJ, Sayers RD. Methicillin-resistant Staphylococcus aureus infection in vascular surgical patients. Ann R Coll Surg Engl. 2001;83:158-63.

McManus AT, Goodwin CW, Pruitt BA Jr. Observations on the risk of resistance with the extended use of vancomycin. Arch Surg. 1998;133:1207-11.

Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med. 1987;316:927-31.

Zanetti G, Goldie SJ, Platt R. Clinical consequences and cost of limiting use of vancomycin for perioperative prophylaxis: example of coronary artery bypass surgery. Emerg Infect Dis. 2001;7:820-7.

Merrer J, Desbouchages L, Serazin V, Razafimamonjy J, Pauthier F, Leneveu M. Comparison of routine prophylaxis with vancomycin or cefazolin for femoral neck fracture surgery: microbiological and clinical outcomes. Infect Control Hosp Epidemiol. 2006;27:1366-71.

Martone WJ. Spread of vancomycin-resistant enterococci: why did it happen in the United States?. Infect Control Hosp Epidemiol. 1998;19:539-45.

Hirose K, Marui A, Arai Y. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection. J Vasc Surg. 2006;44:377-82.

de Lalla F. Antibiotic prophylaxis in orthopedic prosthetic surgery. J Chemother. 2001;1:48-53.

Vardakas KZ, Soteriades ES, Chrysanthopoulou1 A, Papagelopoulos PJ, Falagas ME. Perioperative anti-infective prophylaxis with teicoplanin compared to cephalosporins in orthopaedic and vascular surgery involving prosthetic material. Clin Microbiol Infect. 2005;11:775-7.

de Lalla F, Novelli A, Pellizzer G. Regional and systemic prophylaxis with teicoplanin in monolateral and bilateral total knee replacement procedures: study of pharmacokinetics and tissue penetration. Antimicrob Agents Chemother. 1993;37:2693-8.

Nehrer S, Thalhammer F, Schwameis E, Breyer S, Kotz R. Teicoplanin in the prevention of infection in total hip replacement. Arch Orthop Trauma Surg. 1998;118:32-6.

Mini E, Nobili S, Periti P. Does surgical prophylaxis with teicoplanin constitute a therapeutic advance?. J Chemother. 2000;12:40-55.

Chervu A, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Prevention of graft infection by use of prostheses bonded with a rifampin/collagen release system. J Vasc Surg. 1991;14:521-4.

Harvey RA, Alcid DV, Greco RS. Antibiotic bonding to polytetrafluoroethylene with tridodecylmethylammonium chloride. Surgery. 1982;92:504-12.

Osada T, Yamamura K, Fujimoto K. Prophylaxis of local vascular graft infection with levofloxacin incorporated into albumin-sealed Dacron graft. Microbiol Immunol. 1999;43:317-21.

Bandyk D F, Novotney ML, Back MR, Johnson BL, Schmacht DC. Expanded application of in situ replacement for prosthetic graft infection. J Vasc Surg. 2001;34:411-20.

Goeau-Brissonniere O, Leport C, Bacourt F, Lebrault C, Comte R, Pechere JC. Prevention of vascular graft infection by rifampin bonding to a gelatin-sealed Dacron graft. Ann Vasc Surg. 1991;5:408-12.

Vicaretti M, Hawthorne WJ, Ao PY, Fletcher JP. An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduced the incidence of subsequent graft infections following a staphylococcal challenge. Cardiovasc Surg. 1998;6:268-73.

Ghiselli R, Giacometti A, Goffi L. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed Dacron. J Surg Res. 2001;99:316-20.

Sutherland R, Boon RJ, Griffin KE, Masters PJ, Slocombe B, White AR. Antibacterial activity of mupirocin (pseudomonic acid), a new antibiotic for topical use. Antimicrob Agents Chemother. 1985;27:495-8.

Cookson BD. The emergence of mupirocin resistance: a challenge to infection control and antibiotic prescribing practice. J Antimicrob Chemother. 1998;41:11-8.

Giacometti A, Cirioni O, Ghiselli R. Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides. Antimicrob Agents Chemother. 2002;46:2885-8.